Wang Bing, Xu Yiduo, Wan Peng, Shao Shan, Zhang Feifei, Shao Xiaoliang, Wang Jianfeng, Wang Yuetao
Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China.
Front Cardiovasc Med. 2022 Jul 8;9:862000. doi: 10.3389/fcvm.2022.862000. eCollection 2022.
Atrial fibrillation (AF) is a common arrhythmia, and its most severe and dreaded complication is stroke. The CHADS-VASc score is currently recommended for stroke risk assessment in AF. We aimed to explore the relationship between atrial FDG uptake and stroke and whether atrial FDG uptake could provide incremental value above the CHADS-VAS score to predict stroke in AF by F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT).
From September 2017 to December 2020, we retrospectively enrolled 230 patients (115 with AF and 115 without AF as the non-AF group, matched for the date of PET/CT examination and the basic characteristics of the patient) who underwent F-FDG PET/CT due to tumor screening or preoperative staging after prolonged fasting and followed up for at least 12 months from the date of PET/CT examination; the endpoint event is the occurrence of stroke. We visually and quantitatively analyzed F-FDG uptake in the right and left atria (RA/LA), right and left atrial appendage (RAA/LAA), right and left ventricle (RV/LV), and collected clinical features. In addition, according to the endpoint event (stroke), the enrolled population was divided into the stroke group and non-stroke group, and relevant clinical features and atrial FDG uptake indicators of the two groups were analyzed. Univariate and multivariate Cox regression analyzes were used to analyze the risk factors of stroke events. The Kaplan-Meier survival curve of atrial FDG uptake was drawn, and the log-rank method was used to compare the differences in the survival curves of the two groups. Receiver operating characteristic (ROC) curves were used to examine the discriminatory power of atrial FDG uptake in predicting stroke and determine whether the addition of atrial FDG uptake improves predictive value beyond the CHADS-VASc score for stroke.
In the AF group, more than half of patients had RA FDG uptake and one-fifth had LA FDG uptake, while one patient had RA FDG uptake and two patients had LA FDG uptake in the non-AF group. In quantitative analysis, the maximum standardized uptake value (SUV ) of the RA and LA in the AF group was significantly higher than that of the non-AF group (all < 0.001). We followed up the patients for 28 ± 10 months, and finally, 31 patients had stroke. In the stroke group, atrial fibrillation, RA SUV , RAA SUV , LAA SUV , age ≥ 75 years, and left atrial dilation were significantly higher than those of the non-stroke group (all < 0.05). Multivariate Cox regression analysis showed that high RA SUV (RA SUV ≥ 2.62) was an independent risk factor for stroke (HR = 4.264, 95% CI 1.368-13.293, = 0.012). By using the log-rank test, patients with high RA SUV had a significantly higher incidence of stroke compared with patients with low RA SUV ( < 0.001). Addition of high RA SUV to the CHADS-VASc score could predict stroke more effectively, with a larger AUC 0.790 ( < 0.001).
This study found a significant correlation between atrial FDG uptake and AF, especially in RA. Meanwhile, RA FDG uptake is an independent risk factor for stroke, and patients with high RA SUV have a significantly higher risk of stroke. Moreover, RA FDG uptake improves prediction of stroke above the CHADS-VASc score in patients with AF.
心房颤动(AF)是一种常见的心律失常,其最严重且可怕的并发症是中风。目前推荐使用CHADS-VASc评分进行AF患者的中风风险评估。我们旨在探讨心房氟脱氧葡萄糖(FDG)摄取与中风之间的关系,以及心房FDG摄取是否能在CHADS-VAS评分基础上额外提供价值,以通过氟-氟脱氧葡萄糖(F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)预测AF患者的中风。
2017年9月至2020年12月,我们回顾性纳入了230例患者(115例AF患者和115例非AF患者作为非AF组,根据PET/CT检查日期和患者基本特征进行匹配),这些患者因肿瘤筛查或术前分期在长时间禁食后接受了F-FDG PET/CT检查,并从PET/CT检查日期起随访至少12个月;终点事件为中风的发生。我们对右心房(RA)、左心房(LA)、右心耳(RAA)、左心耳(LAA)、右心室(RV)和左心室(LV)的F-FDG摄取进行了视觉和定量分析,并收集了临床特征。此外,根据终点事件(中风)将纳入人群分为中风组和非中风组,分析两组的相关临床特征和心房FDG摄取指标。采用单因素和多因素Cox回归分析中风事件的危险因素。绘制心房FDG摄取的Kaplan-Meier生存曲线,采用对数秩检验比较两组生存曲线的差异。采用受试者工作特征(ROC)曲线检验心房FDG摄取对中风的预测能力,并确定添加心房FDG摄取是否能提高CHADS-VASc评分对中风的预测价值。
在AF组中,超过一半的患者有RA FDG摄取,五分之一的患者有LA FDG摄取,而非AF组中1例患者有RA FDG摄取,2例患者有LA FDG摄取。在定量分析中,AF组RA和LA的最大标准化摄取值(SUVmax)显著高于非AF组(均P<0.001)。我们对患者随访了28±10个月,最终31例患者发生中风。中风组的心房颤动、RA SUVmax、RAA SUVmax、LAA SUVmax、年龄≥75岁和左心房扩大均显著高于非中风组(均P<0.05)。多因素Cox回归分析显示,高RA SUVmax(RA SUVmax≥2.62)是中风的独立危险因素(HR = 4.264,95%CI 1.368-13.293,P = 0.012)。通过对数秩检验,高RA SUVmax患者的中风发生率显著高于低RA SUVmax患者(P<0.001)。在CHADS-VASc评分中添加高RA SUVmax可更有效地预测中风,AUC更大,为0.790(P<0.001)。
本研究发现心房FDG摄取与AF之间存在显著相关性,尤其是在RA中。同时,RA FDG摄取是中风的独立危险因素,高RA SUVmax患者的中风风险显著更高。此外,RA FDG摄取可提高CHADS-VASc评分对AF患者中风的预测能力。